Beispiel fuer einen Response Befund - MII IG Kerndatensatz-Modul Molekulares Tumorboard v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Observation: Beispiel fuer einen Response Befund

English

Profile: MII PR MTB Response Befund version: 2027.0.0-ballot.1

partOf: Procedure Zytostatische Chemotherapie, Immuntherapie und antiretrovirale Therapie

status: Registered

code: Status of regression of tumor (observable entity)

subject: Maxim Muster (no stated gender), DoB Unknown

focus: Condition Bösartige Neubildung: Peritoneum, nicht näher bezeichnet

effective: 2014-02-12

value: Progressive Disease

method: RECIST

Components

Code

Value[x]

Status of residual neoplasm (observable entity)

Kein Tumor nachweisbar

IG © 2024+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.mtb#2027.0.0-ballot.1 based on FHIR 4.0.1. Generated 2026-09-15
Links: Table of Contents | QA Report | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Legal notice
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.